Therapeutic Candidate or Device CRISPR corrected blood stem cells are manufactured from persons with severe sickle cell disease and returned by transplant to the same person Indication Persons with sickle…
Therapeutic Candidate or Device ECT-001 graft contains more stem and immune cells than conventional cord blood graft, leading to prompt recovery and better outcomes for patients. Indication Severe Sickle Cell…
Clinical trials are risky and rely on brave pioneers who are willing to put their bodies on the line to test something never before tried in people. At its December…
Using a mix of science, humor and easy to understand language, this video describes sickle cell disease and a CIRM-funded clinical trial at UCLA that is testing a stem cell…
Dr. Robert Vescio spoke to CIRM's governing board to promote awareness about amyloidosis, a rare, often fatal disease caused by the abnormal deposit of proteins called amyloids in various tissues…
Michael York, star of films such as Cabaret, Logan's Run, and Austin Powers, spoke to the California stem cell agency governing board about his personal battle with amyloidosis, a rare,…
This seminar, presented to the CIRM governing board on January 17th, 2012, provides a glimpse into a future of personalized medicine in which genomics, the study of genes and their…
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
